C22.0

C22.0: Liver cell carcinoma

Billable / specific codeICD-10-CM

C22.0 is a billable, specific ICD-10-CM code for liver cell carcinoma. It is valid for submission on a claim.

Check C22.0 with the rest of the claim: free scrubber

Inclusion terms

Alternative wordings a physician may use in the chart for this same code.

Hepatocellular carcinoma
Hepatoma

Excludes1 inherited from the categories above C22.0

A category’s note binds every code beneath it.

Written on C22: Malignant neoplasm of liver and intrahepatic bile ducts

malignant neoplasm of biliary tract NOS (C24.9)
secondary malignant neoplasm of liver and intrahepatic bile duct (C78.7)

Risk adjustment

C22.0 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:

HCC 20 Lung and Other Severe Cancers1.136 RAF

Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.

Medicare coverage

C22.0 is named in 69 Medicare coverage policies: 69 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

A52370Billing and Coding: Bevacizumab and biosimilars
A52479Oral Anticancer Drugs - Policy Article
A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
A52986Billing and Coding: Biomarkers for Oncology

Alphabetic index entries that lead here

Cholangiohepatoma
Hepatocarcinoma
Hepatocholangiocarcinoma
Hepatoma(malignant)
Cancer›hepatocellular
Carcinoma›hepatic cell
Carcinoma›hepatocellular
Carcinoma›hepatocholangiolitic
Carcinoma›liver cell
Cholangiocarcinoma›with hepatocellular carcinoma, combined
Embryoma›liver
Hepatoma›embryonal

Code history

Unchanged in every release from FY2024 to FY2027.